P

Phio Pharmaceuticals Corp

D
PHIO
USD
0
(0%)
Market Closed
1,985.00
حجم التداول
-16.38
الربح لكل سهم
-
العائد الربحي
-0.201488
P/E
2,797,343.25
حجم السوق
اليوم
0.0000%
1 اسبوع
8.333%
1 شهر
8.696%
6 اشهر
-57.046%
12 اشهر
-70.641%
بداية السنة
-53.078%
كل الوقت
0%

Title:
Phio Pharmaceuticals Corp

Sector:
Healthcare
Industry:
Biotechnology
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
هل تحتاج مساعدة او لديك استفسار؟